Non-Alcoholic Fatty Liver Disease (NAFLD), now termed Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD), is rising ...

and even rapid weight loss. The NAFLD category ignores this etiological diversity. The development of MAFLD as a diagnostic category to replace NAFLD is intended to bring these well-established ...

Nonpharmacologic modalities for treating NAFLD, such as weight loss, aim to improve IR. The pharmacologic agents used in treating NAFLD include insulin-modulating, lipid-modulating, fibrosis ...

One participant lost 22% of her weight in nine months — substantially faster than the rate seen with approved GLP-1 drugs ...

It can help people with fatty liver disease lose weight, improve liver health, and reduce complications. With an average loss of over 11 kg in one year, semaglutide could be a promising treatment ...